References
- Raimundo K, Chang E, Broder MS, et al. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med. 2016;16:2. doi:https://doi.org/10.1186/s12890-015-0165-1.
- Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009;2(2):103–121. doi:https://doi.org/10.1038/mi.2008.85.
- Brandes ME, Mai UE, Ohura K, et al. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J Immunol. 1991;147(5):1600–1606.
- Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol. 1994;152(12):5860–5867.
- Wahl SM. Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med. 1994;180(5):1587–1590. doi:https://doi.org/10.1084/jem.180.5.1587.
- Lyons RM, Moses HL. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem. 1990;187(3):467–473. doi:https://doi.org/10.1111/j.1432-1033.1990.tb15327.x.
- Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;6(1):597–641. doi:https://doi.org/10.1146/annurev.cb.06.110190.003121.
- Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol. 1992;119(5):1017–1021. doi:https://doi.org/10.1083/jcb.119.5.1017.
- Zhao J, Shi W, Wang YL, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol. 2002;282(3):L585–593. doi:https://doi.org/10.1152/ajplung.00151.2001.
- Stahnke T, Kowtharapu BS, Stachs O, et al. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro. PLoS One. 2017;12(2):e0172592. doi:https://doi.org/10.1371/journal.pone.0172592.
- Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature’s biological glues. Biochem J. 2002;368(Pt 2):377–396. doi:https://doi.org/10.1042/BJ20021234.
- Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol. 2003;4(2):140–156. doi:https://doi.org/10.1038/nrm1014.
- Gundemir S, Colak G, Tucholski J, et al. Transglutaminase 2: A molecular Swiss army knife. Biochim Biophys Acta. 2012;1823(2):406–419. doi:https://doi.org/10.1016/j.bbamcr.2011.09.012.
- Munger JS, Harpel JG, Gleizes P-E, et al. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int. 1997;51(5):1376–1382. doi:https://doi.org/10.1038/ki.1997.188.
- Nunes I, Gleizes P-E, Metz CN, et al. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol. 1997;136(5):1151–1163. doi:https://doi.org/10.1083/jcb.136.5.1151.
- Olsen KC, Sapinoro RE, Kottmann R, et al. Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184(6):699–707. doi:https://doi.org/10.1164/rccm.201101-0013OC.
- Liu Z, Kuang W, Zhou Q, et al. TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway. Int J Mol Med. 2018;42(6):3395–3403. doi:https://doi.org/10.3892/ijmm.2018.3923.
- Martinez FO, Helming L, Milde R, et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood. 2013;121(9):e57–e69. doi:https://doi.org/10.1182/blood-2012-06-436212.
- Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med. 2004;200(3):377–389. doi:https://doi.org/10.1084/jem.20040104.
- De Laurenzi V, Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol. 2001;21(1):148–155. doi:https://doi.org/10.1128/MCB.21.1.148-155.2001.
- Tóth B, Garabuczi É, Sarang Z, et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol. 2009;182(4):2084–2092. doi:https://doi.org/10.4049/jimmunol.0803444.
- Morimoto K, Janssen WJ, Terada M. Defective efferocytosis by alveolar macrophages in IPF patients. Respir Med. 2012;106(12):1800–1803. doi:https://doi.org/10.1016/j.rmed.2012.08.020.
- Kang HR, Cho SJ, Lee CG, et al. Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J Biol Chem. 2007;282(10):7723–7732. doi:https://doi.org/10.1074/jbc.M610764200.
- Kang HR, Lee CG, Homer RJ, et al. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J Exp Med. 2007;204(5):1083–1093. doi:https://doi.org/10.1084/jem.20061273.
- Li L, Zhang S, Wei L, et al. FGF2 and FGFR2 in patients with idiopathic pulmonary fibrosis and lung cancer. Oncol Lett. 2018;16(2):2490–2494. doi:https://doi.org/10.3892/ol.2018.8903.
- Nar H, Werle K, Bauer MM, et al. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. J Mol Biol. 2001;312(4):743–751. doi:https://doi.org/10.1006/jmbi.2001.4953.
- Akhurst RJ, Hata A. Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov. 2012;11(10):790–811. doi:https://doi.org/10.1038/nrd3810.
- Makinde T, Murphy RF, Agrawal DK. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol. 2007;85(5):348–356. doi:https://doi.org/10.1038/sj.icb.7100044.
- Halwani R, Al-Muhsen S, Al-Jahdali H, et al. Role of transforming growth factor-β in airway remodeling in asthma . Am J Respir Cell Mol Biol. 2011;44(2):127–133. doi:https://doi.org/10.1165/rcmb.2010-0027TR.
- Morris DG, Huang X, Kaminski N, et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature. 2003;422(6928):169–173. doi:https://doi.org/10.1038/nature01413.
- Magnan A, Frachon I, Rain B, et al. Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells. Thorax. 1994;49(8):789–792. doi:https://doi.org/10.1136/thx.49.8.789.
- Della Latta V, Cecchettini A, Del Ry S, et al. Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions. Pharmacol Res. 2015;97:122–130. doi:https://doi.org/10.1016/j.phrs.2015.04.012.
- Belkin AM. Extracellular TG2: emerging functions and regulation. FEBS J. 2011;278(24):4704–4716. doi:https://doi.org/10.1111/j.1742-4658.2011.08346.x.
- Philp CJ, Siebeke I, Clements D, et al. Extracellular matrix cross-linking enhances fibroblast growth and protects against matrix proteolysis in lung fibrosis. Am J Respir Cell Mol Biol. 2018;58(5):594–603. doi:https://doi.org/10.1165/rcmb.2016-0379OC.
- Shweke N, Boulos N, Jouanneau C, et al. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol. 2008;173(3):631–642. doi:https://doi.org/10.2353/ajpath.2008.080025.
- Johnson TS, Fisher M, Haylor JL, et al. Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J Am Soc Nephrol. 2007;18(12):3078–3088. doi:https://doi.org/10.1681/ASN.2006070690.
- Szondy Z, Sarang Z, Molnar P, et al. Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci USA. 2003;100(13):7812–7817. doi:https://doi.org/10.1073/pnas.0832466100.
- Garabuczi E, Kiss B, Felszeghy S, et al. Retinoids produced by macrophages engulfing apoptotic cells contribute to the appearance of transglutaminase 2 in apoptotic thymocytes. Amino Acids. 2013;44(1):235–244. doi:https://doi.org/10.1007/s00726-011-1119-4.
- Cao L, Shao M, Schilder J, et al. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene. 2012;31(20):2521–2534. doi:https://doi.org/10.1038/onc.2011.429.
- Nunes I, Shapiro RL, Rifkin DB. Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol. 1995;155(3):1450–1459.
- Sime PJ, Marr RA, Gauldie D, et al. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol. 1998;153(3):825–832. doi:https://doi.org/10.1016/s0002-9440(10)65624-6.
- Oh K, Park HB, Byoun OJ, et al. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med. 2011;208(8):1707–1719. doi:https://doi.org/10.1084/jem.20101457.
- Yu X, Buttgereit A, Lelios I, et al. The cytokine TGF-β promotes the development and homeostasis of alveolar macrophages. Immunity. 2017;47(5):903–912.e904. doi:https://doi.org/10.1016/j.immuni.2017.10.007.
- Rossi G, Cavazza A, Spagnolo P, et al. The role of macrophages in interstitial lung diseases: Number 3 in the Series “Pathology for the clinician” Edited by Peter Dorfmüller and Alberto Cavazza. Eur Respir J. 2017;26(145):170009.
- Zhang F, Wang H, Wang X, et al. TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget. 2016;7(32):52294–52306. doi:https://doi.org/10.18632/oncotarget.10561.
- Sun H, Kaartinen MT. Transglutaminases in monocytes and macrophages. Med Sci (Basel). 2018;6(4):115.
- Nie H, Wang A, He Q, et al. Phenotypic switch in lung interstitial macrophage polarization in an ovalbumin-induced mouse model of asthma. Exp Ther Med. 2017;14(2):1284–1292. doi:https://doi.org/10.3892/etm.2017.4699.
- Malyshev I, Malyshev Y. Current concept and update of the macrophage plasticity concept: intracellular mechanisms of reprogramming and M3 macrophage “switch” phenotype. Biomed Res Int. 2015;2015:341308. doi:https://doi.org/10.1155/2015/341308.
- Wang Z, Perez M, Lee E-S, et al. The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition. Cell Death Dis. 2017;8(9):e3032. doi:https://doi.org/10.1038/cddis.2017.399.
- Hoffmann EJ, Ponik SM. Biomechanical contributions to macrophage activation in the tumor microenvironment. Front Oncol. 2020;10:787.